Clinical Trial Update: A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial of tetrodotoxin for chemotherapy-induced neuropathic pain has been terminated; no efficacy results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neuropathic Pain
• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Tetrodotoxin (tetrodotoxin)

Snippet

Sponsor: Wex Pharmaceuticals Inc. | Conditions: Chemotherapy-induced Neuropathic Pain, Chemotherapy-induced Peripheral Neuropathy | Phase 2 | Status: TERMINATED